Targeting chemotherapy with genetic testing benefits women with aggressive breast cancer
Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports.
Apr 30, 2018
0
27